Immunovant
IMVT
IMVT
182 hedge funds and large institutions have $1.53B invested in Immunovant in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 50 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% less capital invested
Capital invested by funds: $1.54B → $1.53B (-$5.64M)
1.71% less ownership
Funds ownership: 56.3% → 54.6% (-1.7%)
41% less call options, than puts
Call options by funds: $7.15M | Put options by funds: $12.1M
Holders
182
Holding in Top 10
6
Calls
$7.15M
Puts
$12.1M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$10.3M | |
| 3 | +$8.21M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.39M |
Top Sellers
| 1 | -$62.4M | |
| 2 | -$27.6M | |
| 3 | -$8.87M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$8.25M |
| 5 |
JP Morgan Chase
New York
|
-$6.5M |
